{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:36:48Z","timestamp":1767706608639,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adult-onset Still\u2019s disease (AOSD) is an autoinflammatory multi-systemic syndrome. Macrophage activation syndrome (MAS) is a potentially life-threatening complication of AOSD with a mortality rate of 10\u201320%. Especially viral infection is thought to be a common trigger for development of MAS. On the other hand, the occurrence of MAS following vaccinations is extremely rare and has been described in a few cases after measles or influenza vaccinations and more recently after ChAdOx1 nCoV-19 (COVID-19 viral vector vaccine, Oxford-AZ).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a twenty-year-old female with adult-onset Still\u2019s disease (AOSD), who developed a MAS six days after receiving her first COVID-19 vaccine dose of BNT162b2 (mRNA vaccine, BioNTech\/Pfizer) with ferritin levels of 136,680\u00a0\u00b5g\/l (ref.: 13\u2013150\u00a0\u00b5g\/l).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To the best of our knowledge, this is the first case report of development of MAS in a patient with preexisting AOSD after vaccination in general, and SARS-CoV-2 vaccination in particular. The new mRNA vaccines have generally shown a reassuring safety profile, but it has been shown that nucleic acids in general, including mRNA can act as pathogen-associated molecular patterns that activate toll-like receptors with extensive production of pro-inflammatory cytokines and further activation of immune cells. Proving an interferon 1 response in our patient directly after vaccination, we think that in this particular case the vaccination might have acted as trigger for the development of MAS. Even if it remains difficult to establish causality in the case of rare adverse events, especially in patients with autoimmune or autoinflammatory conditions, these complications are important to monitor and register, but do not at all diminish the overwhelming positive benefit-risk ratio of licensed COVID-19 vaccines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41927-021-00237-9","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:02:48Z","timestamp":1640649768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Macrophage activation syndrome in a patient with adult-onset Still\u2019s disease following first COVID-19 vaccination with BNT162b2"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-0471","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Muench","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif Erik","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"237_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol. 2014;33:305\u201314.","journal-title":"Clin Rheumatol"},{"key":"237_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3899\/jrheum.121233","volume":"40","author":"R Strippoli","year":"2013","unstructured":"Strippoli R, Caiello I, De Benedetti F. Reaching the threshold: A multilayer pathogenesis of macrophage activation syndrome. J Rheumatol. 2013;40:761\u20137.","journal-title":"J Rheumatol"},{"key":"237_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/491567","volume":"2015","author":"N Hashemi-Sadraei","year":"2015","unstructured":"Hashemi-Sadraei N, Vejpongsa P, Baljevic M, Chen L, Idowu M. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis: hematologic emergency in the critical care setting. Case Rep Hematol. 2015;2015:1\u20136.","journal-title":"Case Rep Hematol"},{"key":"237_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00431-002-1027-4","volume":"161","author":"T Otagiri","year":"2002","unstructured":"Otagiri T, Mitsui T, Kawakami T, Katsuura M, Maeda K, Ikegami T, et al. Haemophagocytic lymphohistiocytosis following measles vaccination. Eur J Pediatr. 2002;161:494\u20136.","journal-title":"Eur J Pediatr"},{"key":"237_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12185-016-2177-x","volume":"105","author":"T Ikebe","year":"2017","unstructured":"Ikebe T, Takata H, Sasaki H, Miyazaki Y, Ohtsuka E, Saburi Y, et al. Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation. Int J Hematol. 2017;105:389\u201391.","journal-title":"Int J Hematol"},{"key":"237_CR6","first-page":"1","volume":"25","author":"L Attwell","year":"2021","unstructured":"Attwell L, Zaw T, McCormick J, Marks J, McCarthy H. Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination. J Clin Pathol. 2021;25:1\u20133.","journal-title":"J Clin Pathol"},{"key":"237_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","volume":"14","author":"LV Tang","year":"2021","unstructured":"Tang LV, Hu Y. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination. J Hematol Oncol. 2021;14:1\u20135.","journal-title":"J Hematol Oncol"},{"key":"237_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s2665-9913(21)00218-6","volume":"9913","author":"F Leone","year":"2021","unstructured":"Leone F, Cerasuolo PG, Bosello SL, Verardi L, Fiori E, Cocciolillo F, et al. Adult-onset Still\u2019s disease following COVID-19 vaccination. Lancet Rheumatol. 2021;9913:21\u20133. https:\/\/doi.org\/10.1016\/s2665-9913(21)00218-6.","journal-title":"Lancet Rheumatol"},{"unstructured":"Atkins M, Bakhshi H, Chaudhri S. Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021.","key":"237_CR9"},{"key":"237_CR10","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613\u201320.","journal-title":"Arthritis Rheumatol"},{"key":"237_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000494034","volume":"10","author":"M Tatematsu","year":"2018","unstructured":"Tatematsu M, Funami K, Seya T, Matsumoto M. Extracellular RNA sensing by pattern recognition receptors. J Innate Immun. 2018;10:398\u2013406.","journal-title":"J Innate Immun"},{"key":"237_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines-a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379. https:\/\/doi.org\/10.1038\/nrd.2017.243.","journal-title":"Nat Rev Drug Discov"},{"key":"237_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","volume":"41","author":"T Velikova","year":"2021","unstructured":"Velikova T, Georgiev T. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021;41:509\u201318. https:\/\/doi.org\/10.1007\/s00296-021-04792-9.","journal-title":"Rheumatol Int"},{"key":"237_CR14","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.smim.2019.101300","volume":"43","author":"BX Wang","year":"2019","unstructured":"Wang BX, Fish EN. Global virus outbreaks: Interferons as 1st responders. Semin Immunol. 2019;43:101300.","journal-title":"Semin Immunol"},{"key":"237_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/annrheumdis-2012-201586","volume":"72","author":"T Rose","year":"2013","unstructured":"Rose T, Gr\u00fctzkau A, Hirseland H, Huscher D, D\u00e4hnrich C, Dzionek A, et al. IFN\u03b1 and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 2013;72:1639\u201345.","journal-title":"Ann Rheum Dis"},{"key":"237_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01606-9","author":"JM Doehn","year":"2021","unstructured":"Doehn JM, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, et al. CD169\/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021. https:\/\/doi.org\/10.1007\/s15010-021-01606-9.","journal-title":"Infection"},{"key":"237_CR17","first-page":"1","volume":"Cid","author":"UM Geisen","year":"2021","unstructured":"Geisen UM, Berner DK, Tran F, S\u00fcmb\u00fcl M, Vullriede L, Ciripoi M, et al. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis. 2021;Cid:1\u20136.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-021-00237-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:03:12Z","timestamp":1640649792000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-021-00237-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1186\/s41927-021-00237-9","relation":{},"ISSN":["2520-1026"],"issn-type":[{"type":"electronic","value":"2520-1026"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no ethical vote for simple case report needed when a signed patient consent is present at our institution: the patient gave written consent for publication of personal or clinical details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written consent for her personal or clinical details to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}